tweenvest

Obsidian Therapeutics, Inc. (NasdaqCM: OBX)

Health Care · Biotechnology · US

$12.21

+1.16% today · +78.5% 1Y

Public summary
A free snapshot of Obsidian Therapeutics, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Obsidian Therapeutics, Inc. (NasdaqCM: OBX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $754.25M and employs 87 people.

Over the last twelve months the share price has gained 78.5%, trading between 5.70 and 49.97.

Tweenvest scores Obsidian Therapeutics, Inc. across four factors: quality 44/100, value 57/100. Its strongest factor is value.

OBX price history

Nov 21, 2025 · 6.01Weekly closes 6.01 – 28.52Nov 18, 2026 · 12.21

Key figures

Market cap
$754.25M
Revenue (TTM)
—
P/E
-9.08
EPS
-2,056.18
Dividend yield
—
Beta (5Y)
3.06
52-week high
$49.97
52-week low
$5.70
Avg volume (3M)
—
Shares outstanding
61.77M
Employees
87
Next earnings
—

About Obsidian Therapeutics, Inc.

A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.

ISIN
US67448A1060
Founded
2015
Listed since
Aug 4, 2026
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Ardelyx, Inc.NasdaqGM: ARDX$784.28M$3.12-1.89%
ORIC Pharmaceuticals, Inc.NasdaqGS: ORIC$779.47M$7.52-4.33%
Monte Rosa Therapeutics, Inc.NasdaqGS: GLUE$775.03M$9.070.00%
Kolon TissueGene, Inc.KOSDAQ: A950160$772.30M₩12,150.00-3.19%
Inventiva S.A.ENXTPA: IVA$753.92M€2.91+0.69%
Ingenia Therapeutics Inc.KOSDAQ: A950260$752.71M₩20,350.00+1.24%
Nanjing Leads Biolabs Co., Ltd.SEHK: 9887$748.03MHK$30.08-1.96%
Beijing SL Pharmaceutical Co., Ltd.SZSE: 002038$745.83MCN¥4.84-2.22%

Browse every Biotechnology company →